View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 1 / Ipilimumab 3, Melanoma, Malignant, Adjuvant, cycle 1-4
Protocol-ID: 1894 V1.2 (Mini), NIVO1/IPIL3, Melanoma, adj., C1-4Indication(s)
- Melanoma, Malignant; ICD-10 C44.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.01.2023